Belgin Sever

33PUBLICATIONS
48CO-AUTHORS
Biomolecular modelling and designCharacterisation of biological macromoleculesBiologically active moleculesHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 27, 2026
Structural and Computationally Driven Molecule Design in Drug Discovery: Current Advances and Future Perspectives.

|Aug 27, 2026
Design, Synthesis and Biological Evaluation of Novel Oleanolic Acid Derivatives as Potential Anti-Leukemic Agents.

|Jul 28, 2026
Discovery of a Novel 4,5-Dihydro-1H-pyrazole-1-carbothioamide Derivative with Cytotoxic, Apoptotic, and ABL1 Inhibitory Activities Against Chronic Myeloid Leukemia.

|Jun 26, 2026
Targeting ABL Tyrosine Kinase in Chronic Myeloid Leukemia: Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Thiazolone Derivatives.

|Mar 28, 2026
Design, Synthesis, and Biological Evaluation of N,N-Diphenylaniline-Based Derivatives as Antiproliferative Agents and ABL TK Inhibitors Against CML.

Belgin Sever, Halilibrahim Ciftci

|Jan 28, 2026
Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity.

Belgin Sever, Cüneyt Türkeş, Yeliz Demir

Pageof 6

Frequent Collaborators

24 joint publications

Halilibrahim Ciftci

13 joint publications

Mikako Fujita

11 joint publications

Mehlika Dilek Altıntop

9 joint publications

Hasan DeMirci